Alpha Tau Medical Warrant (DRTSW)

• Market cap: $17.6M
• 1 day: 3.69%
• 5 days: 9.61%
• 1 month: 8.65%
• 3 months: -10.75%
• 6 months: 53.22%
• Year to date: 4.13%
• 1 year: 13.64%
• 5 years: -49.00%
• 10 years: -49.00%
• Sector: Healthcare
• Industry: Biotechnology

About: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Employees: 125

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1.73% less ownership

Funds ownership: 4.66% [Q4 2024] → 2.93% (-1.73%) [Q1 2025]

12% less funds holding

Funds holding: 26 [Q4 2024] → 23 (-3) [Q1 2025]

31% less capital invested

Capital invested by funds: $681K [Q4 2024] → $473K (-$208K) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3